Summary of CD19 and CD20 expression during B cell development. CD19... | Download Scientific Diagram
CD20 as a gatekeeper of the resting state of human B cells | PNAS
Get an Overview of B Cell- CUSABIO
Effector and regulatory B cells in immune-mediated kidney disease | Nature Reviews Nephrology
Establishment of C20Mab‑11, a novel anti‑CD20 monoclonal antibody, for the detection of B cells
B Cell Overview | Thermo Fisher Scientific - US
CD antigens expression in B cells | Sino Biological
CD antigens expression in B cells | Sino Biological
International Clinical Cytometry Society
CD20 as a gatekeeper of the resting state of human B cells | PNAS
A Guide to Plasma Cell Markers | Biocompare: The Buyer's Guide for Life Scientists
Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis - ScienceDirect
B cell depletion therapies in autoimmune disease: advances and mechanistic insights | Nature Reviews Drug Discovery
Cells | Free Full-Text | Ocrelizumab Depletes CD20+ T Cells in Multiple Sclerosis Patients
Immunophenotyping of B Cells by Flow Cytometry | Bio-Rad
B-cell subpopulations in humans and their differential susceptibility to depletionwith anti-CD20 monoclonal antibodies | Arthritis Research & Therapy | Full Text
Frontiers | Memory B Cells in Multiple Sclerosis: Emerging Players in Disease Pathogenesis
A Guide to B Cell Markers | Biocompare: The Buyer's Guide for Life Scientists
Brain Sciences | Free Full-Text | Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab
Immunohistochemistry showing (A) positive CD20, a marker of B cell... | Download Scientific Diagram
CD20 as a gatekeeper of the resting state of human B cells | PNAS
The regulation and function of CD20: an “enigma” of B-cell biology and targeted therapy | Haematologica
Frontiers | Delineating Human B Cell Precursor Development With Genetically Identified PID Cases as a Model
Anti-CD20–mediated B-cell depletion in autoimmune diseases: successes, failures and future perspectives
B Cell Overview | Thermo Fisher Scientific - US
International Clinical Cytometry Society
Anti-CD20 therapies for multiple sclerosis: current status and future perspectives | SpringerLink
